A robust response to high-dose plasma, prednisolone, and rituximab in an infant with acquired thrombotic thrombocytopenic purpura.
Mari SuzukiKatsuyoshi ShimozawaHiroshi YagasakiMasaru UenoMaiko HiraiMasanori MatsumotoIchiro MoriokaPublished in: Pediatric blood & cancer (2023)